Tazimide 1.125gm Injection
Marketer
Cachet Pharmaceuticals Pvt Ltd
Salt Composition
Ceftazidime (1.125gm)
Overview Tazimide 1.125gm Injection
Ceftazidime 1.125g injection is an antibacterial medication combating various bacterial infections. Its efficacy spans infections affecting the brain, lungs, ears, urinary system, skin and subcutaneous tissues, bones and joints, bloodstream, and heart. Prophylactic use is also indicated during surgical procedures. This injectable medication inhibits bacterial growth, alleviating symptoms and resolving the underlying infection. Administered intravenously or intramuscularly by a healthcare provider, the dosage is determined individually. Consistent, evenly spaced doses, as directed, are crucial. Complete the prescribed course; premature cessation risks relapse or infection exacerbation. Common adverse effects include skin rashes and diarrhea; transient injection site redness or pain may also occur. Report persistent or bothersome side effects. Prior to administration, disclose any antibiotic allergies, liver or kidney issues, and all other medications currently being used, as interactions may occur. Consult your physician before use if pregnant or breastfeeding.
Primary Ingredients of Tazimide 1.125gm Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Tazimide 1.125gm Injection
Infections caused by bacteria
Major Benefits of Tazimide 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tazimide 1.125gm Injection:
- Rash
- Allergic reaction
- Injection site reaction
- Diarrhea
How to use Tazimide 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazimide 1.125gm Injection works:
The antibiotic Tazimide 1.125gm Injection works by disrupting bacterial cell wall synthesis, thus eliminating bacteria through the inhibition of their essential protective layer.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Tazimide 1.125gm Injection.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Tazimide 1.125gm Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Tazimide 1.125gm Injection safely. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant. However, to minimize potential side effects like rash or diarrhea, avoid extended use of Tazimide 1.125gm Injection.
DrivingUNSAFE
The administration of Tazimide 1.125gm Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should receive Tazimide 1.125gm Injection only with careful monitoring. Dosage modification for Tazimide 1.125gm Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tazimide 1.125gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tazimide 1.125gm Injection :
Omit a dose of Tazimide 1.125gm Injection? Seek medical advice immediately.
Facts to Know About Tazimide 1.125gm Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-spectrum cephalosporins (generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
| Behavioral Class | Third-generation cephalosporins |
3,018 People bought this recently